Skip to content

Physical Activity in Children With Inherited Cardiac Diseases

Physical Activity in Children With Inherited Cardiac Diseases : a Qualitative

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04650009
Enrollment
28
Registered
2020-12-02
Start date
2020-05-01
Completion date
2021-02-01
Last updated
2022-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brugada Syndrome, Catecholaminergic Polymorphic Ventricular Tachycardia, Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, Long QT Syndrome

Keywords

Arrythmogenic right ventricular cardiomyopathy, Physical activity, Inherited cardiac disease, Peadiarics

Brief summary

Use lay language. Current guidelines regarding physical activity in patients with inherited arrhythmia and cardiomyopathy are mostly dedicated to adult patients, with a special focus on sports competition. Their application to the pediatric population has been scarcely evaluated. Physical activity is well known for its health benefits but may be dangerous in this population, which leads to confusion within the medical community and among patients. Actual physical activity of children with such inherited cardiac disorders is unknown. This study aimed to assess the level of physical activity in children with inherited arrhythmia and cardiomyopathy, and the adherence to the current European guidelines on the subject. Secondary objectives aimed to assess through a qualitative analysis the impact of the disease on physical activity and daily life in this population. The level of physical activity and adherence to current guidelines will be determined from interviews between the patient and the principal investigator. Each patient will be questioned in order to explore the experiences, motivations and feelings of participants regarding physical activity. The standardized questionnaire was created by the principal investigator and members of the clinical research team. The investigators believe that many children practice physical activity outside the current guidelines and hope to identify the main determinants of physical activity in this population.

Interventions

None listed

Sponsors

Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

Children from 6 to 18 years old with clinical and/or genetic diagnosis of : * Long QT syndrome * Brugada syndrome * Catecholaminergic polymorphic ventricular tachycardia * Hypertrophic cardiomyopathy * Dilated cardiomyopathy * Arrythmogenic right ventricular cardiomyopathy

Exclusion criteria

* Presence of extra cardiac co-morbidity with motor or psychological repercussions hingering physical activity * Refusal from children or parent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Proportion of children with inheritec cardiac disorders respecting the current European guidelines on sports cardiology and exercise (ESC 2020).1 dayPatient's physical activity will be analysed to evaluate the adherence to current European guidelines regarding physical activity. Patients will be categorized into 3 groups, upon the level of adherence to the guidelines (complete adherence, partial adherence et no adherence).

Secondary

MeasureTime frameDescription
Qualitative analysis evaluating the psychological and emotional impact of physical activity restriction on daily life.1 dayPatients will be interviewed by the principal investigator for 20 to 30 minutes with a focus on physical activity, in order to collect motivations, feelings and discourse of the patient, classified in main themes (positive, negative or neutral). No score is used in this study: The secondary outcome is a qualitative analysis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026